- The distinction between the subjective and objective responsibility - NS judgment about the nature of lawyer liability for damage2013 | Faculty of Law
- Objective response and time to progression on sequential treatment with sunitinib and sorafenib in metastatic renal cell carcinoma2012 | First Faculty of Medicine
- Nonconvulsive status epilepticus in rats: impaired responsiveness to exteroceptive stimuli2000 | Second Faculty of Medicine
- Story of a football coach playing guitar2019 | First Faculty of Medicine
- What is the future of digestive endoscopy?2007 | First Faculty of Medicine
- Combination of Circulating Tumour DNA and 18F-FDG PET/CT for Precision Monitoring of Therapy Response in Patients With Advanced Non-small Cell Lung Cancer: A Prospective Study2022 | Faculty of Medicine in Pilsen, Faculty of Science, Central Library of Charles University
- Can Previous Chemotherapy Affect the Outcome of Nivolumab Treatment in Non-small Cell Lung Cancer?2022 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Cobimetinib - progress in the treatment of melanoma2017 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Activity of fulvestrant in HER2-overexpressing advanced breast cancer2010 | First Faculty of Medicine
- Niraparib2021 | First Faculty of Medicine
- Killing two birds with one stone: response to pembrolizumab in a patient with metastatic melanoma and B-cell chronic lymphocytic leukaemia2018 | Third Faculty of Medicine
- Commenting on the study: efficacy and safety of maintenance treatment with pemetrexed in patients with advanced NSCLC nonskvamózním after induction therapy with pemetrexed plus cisplatin - comparison studies JMBD and PARAMOUNT2014 | Publication without faculty affiliation
- Metastatic melanoma - when and how it should by treated2016 | Publication without faculty affiliation
- Osimertinib - a new treatment option for patients with EGFR mutation T790M2017 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study2023 | First Faculty of Medicine
- Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: An individual patient data meta-analysis2007 | Third Faculty of Medicine
- Efficacy and Safety of Bevacizumab-Based Therapy in Efficacy and safety of bevacizumab-based therapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer in the phase III BO17704 study (AVAiL) Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer in the Phase III BO17704 Study (AVAiL)2010 | Third Faculty of Medicine
- Ixabepilone Alone or With Cetuximab as First-Line Treatment for Advanced/Metastatic Triple-Negative Breast Cancer2015 | Publication without faculty affiliation
- Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition2020 | Second Faculty of Medicine
- Larotrectinib2020 | Publication without faculty affiliation
- Aflibercept for patients with metastatic colorectal cancerPublication without faculty affiliation
- Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung Cancer: AVAiL2009 | Third Faculty of Medicine
- Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma2015 | Second Faculty of Medicine
- Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapy2017 | Faculty of Medicine in Hradec Králové
- Administration of Nivolumab in Metastatic Renal Cell Cancer Following Treatment With mTOR Inhibitors2021 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Hepatic arterial infusion in gastric carcinoma liver metastases: a pooled analysis of the literature2004 | First Faculty of Medicine
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma2015 | Publication without faculty affiliation
- Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study2019 | First Faculty of Medicine
- Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma2023 | Central Library of Charles University
- Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma2015 | First Faculty of Medicine